chr15-55430674-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_130810.4(DNAAF4):āc.1259C>Gā(p.Ser420Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0969 in 1,610,990 control chromosomes in the GnomAD database, including 8,196 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_130810.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAAF4 | NM_130810.4 | c.1259C>G | p.Ser420Cys | missense_variant | 10/10 | ENST00000321149.7 | |
DNAAF4-CCPG1 | NR_037923.1 | n.1408+1823C>G | intron_variant, non_coding_transcript_variant | ||||
DNAAF4 | NM_001033559.3 | c.*22C>G | 3_prime_UTR_variant | 9/9 | |||
DNAAF4 | NM_001033560.2 | c.1047+4231C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAAF4 | ENST00000321149.7 | c.1259C>G | p.Ser420Cys | missense_variant | 10/10 | 1 | NM_130810.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0854 AC: 12978AN: 152048Hom.: 581 Cov.: 32
GnomAD3 exomes AF: 0.0914 AC: 22874AN: 250224Hom.: 1247 AF XY: 0.0935 AC XY: 12639AN XY: 135230
GnomAD4 exome AF: 0.0981 AC: 143164AN: 1458824Hom.: 7611 Cov.: 31 AF XY: 0.0984 AC XY: 71393AN XY: 725746
GnomAD4 genome AF: 0.0854 AC: 13001AN: 152166Hom.: 585 Cov.: 32 AF XY: 0.0834 AC XY: 6207AN XY: 74394
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at